Acetyl Hexapeptide-3 (Argireline) vs Palmitoyl Tripeptide-1
SNARE complex inhibitor that reduces expression wrinkles through topical neuromuscular modulation — the 'Botox in a bottle' peptide.
Collagen-stimulating matrikine peptide and key component of Matrixyl 3000 for comprehensive anti-aging skin renewal.
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Quick comparison
Dose range
Acetyl Hexapeptide-3 (Argireline)
5–10 %
Palmitoyl Tripeptide-1
0.002–0.002 %
Frequency
Acetyl Hexapeptide-3 (Argireline)
Once daily
Palmitoyl Tripeptide-1
Once daily
Administration
Acetyl Hexapeptide-3 (Argireline)
Topical
Palmitoyl Tripeptide-1
Topical
Cycle length
Acetyl Hexapeptide-3 (Argireline)
Ongoing/indefinite
Palmitoyl Tripeptide-1
Ongoing/indefinite
Onset speed
Acetyl Hexapeptide-3 (Argireline)
Moderate (1-2 weeks)
Palmitoyl Tripeptide-1
Moderate (1-2 weeks)
Evidence level
Acetyl Hexapeptide-3 (Argireline)
Limited human trials
Palmitoyl Tripeptide-1
Limited human trials
Benefit ratings
Expression Wrinkle Reduction
Non-Invasive Treatment
Safety Profile
Collagen Production
Anti-Aging
Skin Firmness
Compound specifications
Acetyl Hexapeptide-3 (Argireline)
Molecular formula
C35H62N14O11S
Molecular weight
887.0 Da
Half-life
Topical stability dependent on formulation; methionine residue susceptible to oxidation; stable at pH 5.5-7.7
Bioavailability
Limited skin penetration (0.22-0.54%); primarily acts at stratum corneum and superficial epidermis; O/W emulsions enhance delivery
CAS number
616204-22-9
Palmitoyl Tripeptide-1
Molecular formula
C30H54N6O5
Molecular weight
578.8 Da
Half-life
Limited data; peptide is susceptible to enzymatic degradation in skin but palmitoylation improves stability compared to unmodified GHK
Bioavailability
Enhanced topical penetration via palmitoyl lipid modification; reaches dermis where fibroblasts reside
CAS number
147732-56-7
Dosing compared
Acetyl Hexapeptide-3 (Argireline)
Topical
5-10% concentration (cream or serum)
Twice daily (morning and evening) · Minimum 28-30 days; ongoing use to maintain effect
Used as a leave-on skin cream or serum. In studies, a 10% formula applied twice a day around the eyes reduced wrinkle depth by about 17% after 15 days and up to 27-30% after 30 days. It works on the skin surface only and is not injected. [1][2]
Palmitoyl Tripeptide-1
Topical
Under 10 ppm (<0.001%) in finished product
Once or twice daily · Ongoing
Customary leave-on cosmetic use is below 10 ppm of active peptide [6]. Pal-GHK is the signal-peptide core of the Matrixyl 3000 blend and is typically paired with Pal-GQPR.
Up to ~0.002% in finished product
Once or twice daily · Ongoing
Upper end of reported survey concentrations for leave-on products [6]. Even at this level the active peptide content is very low, which is normal for palmitoyl signal peptides.
Best suited for
Acetyl Hexapeptide-3 (Argireline)
Individuals seeking non-invasive reduction of expression lines and dynamic wrinkles
Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on individuals seeking non-invasive reduction of expression lines and dynamic wrinkles. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Those with needle phobia who want botulinum toxin-like effects without injections
Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on those with needle phobia who want botulinum toxin-like effects without injections. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
People targeting crow's feet, forehead lines, and glabellar creases
Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on people targeting crow's feet, forehead lines, and glabellar creases. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Individuals looking for preventive anti-wrinkle treatment to slow expression line formation
Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on individuals looking for preventive anti-wrinkle treatment to slow expression line formation. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Palmitoyl Tripeptide-1
Individuals seeking comprehensive collagen stimulation through topical skincare
Palmitoyl Tripeptide-1 is particularly well-suited for individuals focused on individuals seeking comprehensive collagen stimulation through topical skincare. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Those with aging skin showing loss of firmness, elasticity, and density
Palmitoyl Tripeptide-1 is particularly well-suited for individuals focused on those with aging skin showing loss of firmness, elasticity, and density. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
People looking for non-invasive alternatives to injectable collagen treatments
Palmitoyl Tripeptide-1 is particularly well-suited for individuals focused on people looking for non-invasive alternatives to injectable collagen treatments. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Those seeking GHK-based skin benefits without copper peptide formulation complexity
Palmitoyl Tripeptide-1 is particularly well-suited for individuals focused on those seeking ghk-based skin benefits without copper peptide formulation complexity. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Side effects
Acetyl Hexapeptide-3 (Argireline)
Common
- Mild Skin Irritation
- Transient Redness
- Slight Dryness
- Stinging on Compromised Skin
Uncommon
- Contact Dermatitis
Serious
- Allergic Contact Dermatitis
Palmitoyl Tripeptide-1
Common
- Temporary Skin Irritation
- Mild Redness
- Dryness
- Mild Peeling
Uncommon
- Contact Dermatitis
Serious
- Skin Sensitization from Fragmented Peptide
Safety & evidence
Acetyl Hexapeptide-3 (Argireline)
Evidence level
Limited human trials
FDA status
Research compound
Safety overview
Acetyl Hexapeptide-3 demonstrates an excellent safety profile for topical cosmetic use with no serious adverse events reported in clinical studies. At the 10% concentrations used in cosmetic formulations, systemic absorption is minimal and no neurotoxicity has been observed despite its mechanism of action on the neuromuscular junction. The peptide shows a safety margin of approximately 100-fold compared to toxic reference compounds. Primary concerns are limited to local skin irritation in sensitive individuals, such as mild erythema, transient stinging, or contact dermatitis in those with peptide hypersensitivity.
Contraindications
- Known hypersensitivity to acetyl hexapeptide-3 or formulation components
- Active skin infections or open wounds at the application site
- No known systemic contraindications at cosmetic concentrations
- Use with caution in individuals with neuromuscular disorders (theoretical concern)
Palmitoyl Tripeptide-1
Evidence level
Limited human trials
FDA status
Research compound
Safety overview
Palmitoyl tripeptide-1 demonstrates excellent cosmetic safety with GRAS/safe-for-use designation in topical formulations at concentrations up to 2%. No serious adverse events in 20+ years of cosmetic industry use; mild erythema (<1% of subjects) at high concentrations (>5%). Dermal penetration limited to stratum corneum; no systemic absorption in vitro. Compatible with common skincare ingredients.
Contraindications
- Known hypersensitivity to palmitoyl tripeptide-1 or related peptide ingredients
- Active skin infections or severely compromised skin barrier at application site
- Open wounds or actively inflamed dermatitis in treatment area
- No known systemic contraindications for topical cosmetic use
Which is right for you?
Choose Acetyl Hexapeptide-3 (Argireline) if...
- Individuals seeking non-invasive reduction of expression lines and dynamic wrinkles
- Those with needle phobia who want botulinum toxin-like effects without injections
- People targeting crow's feet, forehead lines, and glabellar creases
- Individuals looking for preventive anti-wrinkle treatment to slow expression line formation
Choose Palmitoyl Tripeptide-1 if...
- Individuals seeking comprehensive collagen stimulation through topical skincare
- Those with aging skin showing loss of firmness, elasticity, and density
- People looking for non-invasive alternatives to injectable collagen treatments
- Those seeking GHK-based skin benefits without copper peptide formulation complexity